Arthrodesis Versus Extra-articular Plate Fixation in Lisfranc Injury
NCT ID: NCT01448941
Last Updated: 2021-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2011-10-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interest of Medial Partial Arthrodesis in Degenerative and Inflammatory Damage of Lisfranc Tarsometatarsal Joint.
NCT04937764
Finding the Optimal Aim of Correction in Opening Wedge High Tibial Osteotomy
NCT06134050
Assessment of Foot Alignment and Pressure After Correction of Varus Knee by High Tibial Osteotomy or Total Knee Replacement
NCT05314972
High Tibial Osteotomy With/Without Arthroscopy.
NCT05128851
The Impact of Tibial Tubercle-trochlear Groove Distance and Patellar Height on the Outcome of Isolated Medial Patellofemoral Ligament Reconstruction
NCT03076008
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We preform arthrodesis of TMT 2 and 3 in both groups.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Primary arthrodesis TMT 1
Arthrodesis TMT 1 when instability is present. Primary arthrodesis TMT 2 and 3 when instability present
Primary arthrodesis
Primary arthrodesis
Primary arthrodesis TMT 2 and 3
Primary arthrodesis TMT 2 and 3 when instability is present
Temporary extraarticular plate fixation
Temporary extraarticular plate fixation of TMT 1 when instability is present. Primary arthrodesis TMT 2 and 3 when instability present
Temporary extraarticular plate fixation
Arm 1: Primary arthrodesis TMT 1 Arm 2: Temporary extraarticular plate fixation TMT 1
Primary arthrodesis TMT 2 and 3
Primary arthrodesis TMT 2 and 3 when instability is present
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Temporary extraarticular plate fixation
Arm 1: Primary arthrodesis TMT 1 Arm 2: Temporary extraarticular plate fixation TMT 1
Primary arthrodesis
Primary arthrodesis
Primary arthrodesis TMT 2 and 3
Primary arthrodesis TMT 2 and 3 when instability is present
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-65
Exclusion Criteria
* Previous foot infection or foot pathology on affected side
* Previous surgery to the TMT joints
* Sequelae after previous foot injuries
* Diabetes mellitus, neuropathy and peripheral vascular disease
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Are Haukåen Stødle
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Are H Stødle, cand. med.
Role: PRINCIPAL_INVESTIGATOR
Oslo University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oslo University Hospital
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
206025 (REK-ID)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.